ATCxenograftsweretreatedwithplacebo,40mgkgsoraf.pptVIP

Mice bearing orthotopic ATC xenografts were treated with placebo, 40 mg/kg sorafenib, or 80 mg/kg sorafenib daily for 16 d. Seungwon Kim et al. Mol Cancer Ther 2007;6:1785-1792 ?2007 by American Association for Cancer Research Mice bearing orthotopic ATC xenografts were treated with placebo, 40 mg/kg sorafenib, or 80 mg/kg sorafenib daily for 16 d. A, representative tumors from each group. B, columns, mean tumor volumes for each group; bars, SD.